Trial record 1 of 1 for: nct01094691
Previous Study | Return to List | Next Study
Haufen Diagnostic Biomarkers of BK Renal Disease
This study is enrolling participants by invitation only.
University of North Carolina, Chapel Hill
Astellas Pharma US, Inc.
Information provided by (Responsible Party):
Volker Nickeleit, MD, University of North Carolina, Chapel Hill
First received: March 25, 2010
Last updated: April 14, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is enrolling participants by invitation only.|
|Estimated Study Completion Date:||June 2017|
|Estimated Primary Completion Date:||December 2016 (Final data collection date for primary outcome measure)|